A multi-center international study to identify biomarkers of the persistence of KDIGO stage 3 AKI in ICU patients with AKI KDIGO stage 2 or 3 found that higher levels of urinary C-C motif chemokine ligand 14 (CCL-14) predicted the persistence of renal dysfunction [60]. The gene discussed is CCL14; the disease is acute kidney injury.